Aetna Inc. Has Bold Ambitions In A Changing Health Insurance World

Aggressive exchange participation and a focus on accountable care could drive significant performance in Aetna's shares.

Jan 8, 2014 at 6:15PM

Not to belabor the point, but the Affordable Care Act (perhaps better known as "ObamaCare") is going to change the health insurance market in some pretty significant ways – even though the actual percentage of uninsured Americans isn't/wasn't as large as many people guess. In any event, Aetna (NYSE:AET) is approaching this new environment rather boldly. Not only has Aetna put other insurers like UnitedHealth (NYSE:UNH) to shame with its participation in health care exchanges, but the company has openly targeted double-digit top and bottom-line growth on a long-term basis.

I do believe Aetna's reach exceeds its grasp. The good news is that the Street isn't fully buying the story either, and actually seems to be undervaluing even a more modest outlook. I expect plenty of noise and turbulence over the next year or two as the sector adapts to the new operating environment, but Aetna looks intriguing right now.

A Big Splash On the State Exchanges

Aetna has made the biggest commitment to the state health exchanges of all the health insurance companies. Aetna is in 17 states, although even that level of participation covers just 30% of the individual markets and less than half of its existing individual book.

How does that level of participation stack up? Including the District of Columbia, WellPoint (NYSE:ANTM) is participating in 14 states, as is Humana (NYSE: HUM). UnitedHealth and Cigna (NYSE:CI) are talking a much more cautious approach, with five states each, while smaller players run the gamut from Molina (NYSE: MOH) at nine states to Health Net (NYSE: HNT) at just three.

There is an important "yeah, but" when considering Aetna's level of participation. While Aetna is in 17 states, it is only really competitive on pricing in 10 states (covering about 15% of covered markets). Aetna is cheaper pretty much across the board in catastrophic plans and cheaper in Bronze, but not really so competitively priced at the Silver and Gold levels.

Counting The Costs? Good Luck!

One of the biggest challenges with the ACA is the uncertainty it creates in the sector's earnings for the next year or two. Aetna thinks utilization will rise from about 1% to around 1.5% to 2% in 2014, but nobody knows. What does appear more certain, though, is that taxes and fees will take a sizable bite out of 2014 earnings.

The risk mitigation options are also a sizable question mark today. The risk adjustment mechanism that adjusts for imbalances between high-risk and low-risk enrollments will be a zero-sum game for the sector, while the risk corridors and reinsurance programs help transfer some of the initial risk to the government. All told, these efforts should keep the margin impacts within a single digit band (plus and minus), but that's still quite a lot when you're talking about an industry with high single-digit operating margins.

What Else Ya Got?

There's a lot more to insurance companies like UnitedHealth, WellPoint, and Aetna than the extent of their participation in the state exchanges. Accountable care organizations (ACOs) are getting more and more attention, and Aetna believes its approach can save customers in the neighborhood of 8% to 15%. ACOs are basically collaborative organizations between health care providers and payers, in which they work together to make better use of preventative care and coordination to lower overall costs, with the benefits being shared/split and payments based more on outcomes than procedures or actions.That said, I expect Cigna, UnitedHealth and WellPoint to all fight hard for share in this market.

Aetna has put most of its integrated health care eggs in the ACO basket. Unlike Humana and WellPoint, Aetna really has not prioritized in-house clinics, and Aetna likewise doesn't match UnitedHealth in the health care IT space (though few do).

Last and by no means least, Aetna is going to be working hard over the next couple of years to drive synergies from the Coventry acquisition. Roughly two-thirds of the targeted synergies should be attainable from relatively simple fixed cost leverage and eliminating overlapping corporate expenses, so I like Aetna's chances of hitting their targets and using the benefits of synergies to preserve free cash flow and ROE during the next couple of years.

The Bottom Line

I value companies like Aetna on a dual-model basis, with a DCF model and an excess returns model. On the DCF side, though I don't believe Aetna will hit it's double-digit revenue growth target through 2020, I do look for long-term free cash flow growth of around 10%. On the excess returns side, I am looking for a long-term ROE of 16.5%, about a point below the trailing 10-year average. For those who pay attention to earnings growth, that ROE model implies a five-year growth rate of about 9%.

Both models generate similar fair values -- $86 for the excess return model and $88 for the DCF model. In either case, it would appear that Aetna may well be significantly undervalued even with a trailing return of over 50% and the shares near a 52-week high.

Want to retire rich? Here are 3 Stock Picks That Could Help

It's no secret that investors tend to be impatient with the market, but the best investment strategy is to buy shares in solid businesses and keep them for the long term. In the special free report, "3 Stocks That Will Help You Retire Rich," The Motley Fool shares investment ideas and strategies that could help you build wealth for years to come. Click here to grab your free copy today.

Stephen D. Simpson, CFA has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group and WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information